Search - tctmd.com

Displaying 221 - 240 of 243

Sort: Relevancy | Date

Presentation JIM 2017

DESolve: A Family of Novel PLLA-Based Scaffolds

Presenter: Martin B. Leon

February 08, 2017

News Conference News ISET 2017

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

Caitlin E. Cox

February 07, 2017

News Daily News

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Todd Neale

February 06, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

News Daily News

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

Michael O'Riordan

February 03, 2017

News Daily News

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

Yael L. Maxwell

January 31, 2017

News Industry News

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

January 30, 2017

Presentation Miami Valves 2017

Progress in Novel Polymer Aortic Valve

Presenter: Amit N. Patel

January 29, 2017

News Daily News

Preliminary Study Explores Feasibility of Performing Robotic PCI From a Remote Location

Todd Neale

January 26, 2017

News Daily News

Conflicts of Interest in the 2013 Cholesterol Guidelines? New Analysis Revisits the Controversy

Caitlin E. Cox

January 17, 2017

News Daily News

Aspirate Contrast to Limit Acute Kidney Injury in Select Coronary Angiography Cases: Maybe, Maybe Not

Yael L. Maxwell

January 09, 2017

News Daily News

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Todd Neale

January 06, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Presentation CCVVC 2016

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

Presenter: Marc P. Bonaca

June 15, 2016

News Conference News ACC 2015

SCOT-HEART Provides Support for Coronary CTA in Angina Management

L.A. McKeown

March 15, 2015

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

Presentation

Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD

Presenter: Jens Wiebe

February 16, 0017

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Partner Content

Registration - PERSPECTIVEs on CTO: New Evidence and Novel Approaches

November 16, 2017

Advertisement

DESolve: A Family of Novel PLLA-Based Scaffolds

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

Progress in Novel Polymer Aortic Valve

Preliminary Study Explores Feasibility of Performing Robotic PCI From a Remote Location

Conflicts of Interest in the 2013 Cholesterol Guidelines? New Analysis Revisits the Controversy

Aspirate Contrast to Limit Acute Kidney Injury in Select Coronary Angiography Cases: Maybe, Maybe Not

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

SCOT-HEART Provides Support for Coronary CTA in Angina Management

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD

Changing Course with Anticoagulation in Secondary Prevention of CAD

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Registration - PERSPECTIVEs on CTO: New Evidence and Novel Approaches

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content